Up‐Regulation of Follistatin‐Like 1 By the Androgen Receptor and Melanoma Antigen‐A11 in Prostate Cancer
- 14 December 2016
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 77 (5) , 505-516
Abstract
BACKGROUND: High affinity androgen binding to the androgen receptor (AR) activates genes required for male sex differentiation and promotes the development and progression of prostate cancer. Human AR transcriptional activity involves interactions with coregulatory proteins that include primate‐specific melanoma antigen‐A11 (MAGE‐A11), a coactivator that increases AR transcriptional activity during prostate cancer progression to castration‐resistant/recurrent prostate cancer (CRPC).METHODS: Microarray analysis and quantitative RT‐PCR were performed to identify androgen‐regulated MAGE‐A11‐dependent genes in LAPC‐4 prostate cancer cells after lentivirus shRNA knockdown of MAGE‐A11. Chromatin immunoprecipitation was used to assess androgen‐dependent AR recruitment, and immunocytochemistry to localize an androgen‐dependent protein in prostate cancer cells and tissue and in the CWR22 human prostate cancer xenograft.RESULTS: Microarray analysis of androgen‐treated LAPC‐4 prostate cancer cells indicated follistatin‐like 1 (FSTL1) is up‐regulated by MAGE‐A11. Androgen‐dependent up‐regulation of FSTL1 was inhibited in LAPC‐4 cells by lentivirus shRNA knockdown of AR or MAGE‐A11. Chromatin immunoprecipitation demonstrated AR recruitment to intron 10 of the FSTL1 gene that contains a classical consensus androgen response element. Increased levels of FSTL1 protein in LAPC‐4 cells correlated with higher levels of MAGE‐A11 relative to other prostate cancer cells. FSTL1 mRNA levels increased in CRPC and castration‐recurrent CWR22 xenografts in association with predominantly nuclear FSTL1. Increased nuclear localization of FSTL1 in prostate cancer was suggested by predominantly cytoplasmic FSTL1 in benign prostate epithelial cells and predominantly nuclear FSTL1 in epithelial cells in CRPC tissue and the castration‐recurrent CWR22 xenograft. AR expression studies showed nuclear colocalization of AR and endogenous FSTL1 in response to androgen.CONCLUSION: AR and MAGE‐A11 cooperate in the up‐regulation of FSTL1 to promote growth and progression of CRPC. Prostate 77:505–516, 2017.Keywords
Funding Information
- National Institutes of Health (P01‐CA77739)
This publication has 61 references indexed in Scilit:
- FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expressionArthritis & Rheumatism, 2011
- Gain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen ReceptorJournal of Biological Chemistry, 2011
- Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung developmentProceedings of the National Academy of Sciences, 2011
- Transcriptional Synergy between Melanoma Antigen Gene Protein-A11 (MAGE-11) and p300 in Androgen Receptor SignalingJournal of Biological Chemistry, 2010
- DIP2A Functions as a FSTL1 ReceptorJournal of Biological Chemistry, 2010
- Melanoma Antigen Gene Protein-A11 (MAGE-11) F-box Links the Androgen Receptor NH2-terminal Transactivation Domain to p160 CoactivatorsJournal of Biological Chemistry, 2009
- Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent MechanismJournal of Biological Chemistry, 2008
- Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantationMolecular Human Reproduction, 2007
- MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206Journal of Cell Biology, 2006
- The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectinCancer Gene Therapy, 2005